Diane Thompson, Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 201 3rd St. 20, Seward, AK 99664 Phone: 907-224-3490 |
Jeanette L Nienaber, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 417 First Avenue, Seward, AK 99664 Phone: 907-224-2273 Fax: 907-224-8501 |
Mr. Timothy W Johnson, MS PA C Physician Assistant Medicare: Medicare Enrolled Practice Location: 33280 Stoney Creek Ave, Seward, AK 99664 Phone: 907-224-7094 Fax: 907-224-7094 |
Lori Landstrom, PA C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 201 3rd Avenue, Suite 201, Seward, AK 99664 Phone: 907-224-3490 Fax: 907-224-5870 |
Brent Alan Ursel, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11724 Seward Hwy, Ste D, Seward, AK 99664 Phone: 907-224-8733 Fax: 907-224-8734 |
Mrs. Rebecca Ivry Moore, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 201 3rd Ave, Suite 201, Seward, AK 99664 Phone: 907-224-4916 Fax: 907-224-5870 |
Mr. David W Norcross, PHYSICIAN ASSISTANT Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: Spring Creek Correctional Center. Betty Cato Drive, Mile 5 Nash Road, Seward, AK 99664 Phone: 190-722-4837 Fax: 190-722-4818 |
News Archive
Nu Skin Enterprises, Inc. (NYSE: NUS) concluded its 25th Anniversary Convention in Los Angeles with record attendance, record product sales and record contributions to its nonprofit foundation. The biannual global distributor convention attracted more than 12,000 distributors from the company's 48 international markets. The largest delegations of sales representatives came from the United States, Japan and Korea.
A University of Houston College of Pharmacy researcher is characterizing a potential therapeutic target to increase heart function following a heart attack, helping alleviate the symptoms of heart failure.
The latest findings on how blood clots form could open the door to the development of new and better-targeted drugs for patients at risk of strokes or heart attacks.
RCT licensee Dyax Corp. has received approval from the U.S. Food and Drug Administration for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.
Regular physical activity could play a role in helping women at high-risk of breast cancer delay the need for drastic preventive measures such as prophylactic mastectomy, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.
› Verified 4 days ago